The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here is one value stock offering a compelling risk-reward profile and two with little support.
Forward P/S Ratio: 1.7x
Pioneering data warehousing technology in the 1980s before “big data” was a common term, Teradata (NYSE:TDC) provides cloud-based data analytics and AI platforms that help large enterprises integrate, analyze, and leverage their data across multiple environments.
Why Do We Pass on TDC?
-
Billings have dropped by 4.4% over the last year, suggesting it might have to lower prices to stimulate growth
-
Gross margin of 59.4% is way below its competitors, leaving less money to invest in areas like marketing and R&D
-
Operating margin didn’t move over the last year, showing it couldn’t increase its efficiency
At $28.06 per share, Teradata trades at 1.7x forward price-to-sales. To fully understand why you should be careful with TDC, check out our full research report (it’s free).
Forward P/E Ratio: 13.9x
With a higher focus on style and aesthetics compared to other large general merchandise retailers, Target (NYSE:TGT) serves the suburban consumer who is looking for a wide range of products under one roof.
Why Should You Dump TGT?
-
Weak same-store sales trends over the past two years suggest there may be few opportunities in its core markets to open new locations
-
Widely-available products (and therefore stiff competition) result in an inferior gross margin of 28% that must be offset through higher volumes
-
Subpar operating margin of 5.2% constrains its ability to invest in process improvements or effectively respond to new competitive threats
Target’s stock price of $109.70 implies a valuation ratio of 13.9x forward P/E. Read our free research report to see why you should think twice about including TGT in your portfolio, it’s free.
Forward P/E Ratio: 11.6x
With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.